Geographic Access to Medication Assisted Treatment for Medicaid Enrollees with Opioid Use Disorder
Geographic Access to Medication Assisted Treatment for Medicaid Enrollees with Opioid Use Disorder
批准号:
10626822
负责人:
Coleman Drake
金额:
$17.33万
依托单位国家:
美国
项目类别:
财政年份:
2020
资助国家:
美国
项目状态:
已结题
起止时间:
2020-07-01 至 2024-06-30
关键词:
AddressAdherenceAdministratorAffectAmericanBehavior TherapyBuprenorphineCatchment AreaCharacteristicsClinicCommunitiesDataEnrollmentEnsureEvaluationEvidence based treatmentExpenditureFaceFundingFutureGeographic LocationsGeographyGoalsGrantHealthHealth PersonnelHealth Services AccessibilityHot SpotImprove AccessIndividualInformation DisseminationInfrastructureInterventionInvestmentsKnowledgeLiteratureLow Income PopulationLow incomeMeasurementMeasuresMedicaidMentorshipMethadoneMethodsModelingNaltrexoneNational Institute of Drug AbuseOpioidOutcomeOverdosePatientsPennsylvaniaPharmaceutical PreparationsPoliciesPolicy MakerPopulationProviderPublic HealthRecoveryRegulationResearchResearch PersonnelResource AllocationServicesStatistical MethodsTelemedicineTimeTrainingTransportationTravelUnderserved PopulationUnited States National Institutes of HealthUniversitiesVariantVisitWithdrawal Symptomaccess disparitiescravingeffective interventionethnic minoritygeographic populationimprovedinnovationmedication-assisted treatmentmethadone treatmentmultidisciplinarynovelopioid epidemicopioid overdoseopioid use disorderracial minorityrural areasocioeconomic disadvantagesocioeconomicsspatial epidemiologytreatment program
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Abstract
Medication assisted treatment (MAT) is an evidence-based treatment for opioid use disorder (OUD) involving
medication and behavioral therapy. Despite massive public expenditures to increase MAT access, MAT use
remains low. Limited geographic access to MAT is a key barrier to OUD treatment because MAT requires
frequent travel to providers. While expanding geographic access to MAT has been a policy priority,
policymakers lack reliable, accurate measures of geographic access to MAT to guide planning efforts. The
overall objectives of this proposal are to determine where and for whom geographic access to MAT is limited,
and to examine how geographic access to MAT affects OUD-related health outcomes. The hypotheses are
that geographic access to MAT is lower for disadvantaged socioeconomic groups, and that increased
geographic access to MAT improves OUD-related health outcomes. The rationale for this project is that
improved measurement of geographic access to MAT will enable policymakers to implement targeted, effective
interventions to increase MAT access and use. The applicant will use Pennsylvania Medicaid claims to
address the following specific aims: (1) Characterize variation in geographic access to MAT providers by car
and public transit; (2) Identify patient and environmental characteristics associated with geographic access to
MAT; and (3) Determine the impact of geographic access to MAT on MAT use and OUD-related overdoses.
This application is innovative because it will apply novel methods for measuring geographic access to MAT,
including disparities in access by public transit (which is particularly relevant to low-income populations in
Medicaid), and use these measures with causal inference methods to estimate the causal effect of geographic
access to MAT on OUD-related outcomes (including receipt of MAT and opioid overdoses). The proposed
research is significant because it will enable policymakers and researchers to accurately identify small
geographic areas where targeted interventions to improve geographic access to MAT are needed. It also will
estimate how effective such interventions would be. Ultimately, the proposed research will create an evidence
basis from which policymakers can prioritize interventions and allocate resources to efficiently increase
geographic access to MAT. Through a training plan developed with the support of a multi-disciplinary
mentorship team of NIH-funded investigators, this project will enable the applicant to develop a working
knowledge of the treatment of OUD and expertise in MAT policy and geospatial methods. This project also
places an emphasis on dissemination of results to state Medicaid administrators. Collectively, this project will
prepare the applicant to transition to independence by submitting a R01 application to NIDA examining how
various state policies affect OUD-related outcomes through their effects on geographic access to MAT.
期刊论文(10)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Disparities in geographic access to medical oncologists.
接触肿瘤科医生的地域差异。
DOI:
10.1111/1475-6773.13991
发表时间:
2022
期刊:
Health services research
影响因子:
3.4
作者:
[Muluk,Sruthi, Sabik,Lindsay, Chen,Qingwen, Jacobs,Bruce, Sun,Zhaojun, Drake,Coleman]
通讯作者:
Drake,Coleman
DOI:
10.1002/hec.4377
发表时间:
2021-09
期刊:
Health economics
影响因子:
2.1
作者:
[Drake C, Wen J, Hinde J, Wen H]
通讯作者:
Wen H
Recreational cannabis legalizations associated with reductions in prescription drug utilization among Medicaid enrollees.
娱乐性大麻合法化与医疗补助参与者处方药使用量的减少相关。
DOI:
10.1002/hec.4519
发表时间:
2022
期刊:
Health economics
影响因子:
2.1
作者:
[Raman,Shyam, Bradford,AshleyC]
通讯作者:
Bradford,AshleyC
DOI:
10.1016/j.drugalcdep.2021.108633
发表时间:
2021-04-01
期刊:
Drug and alcohol dependence
影响因子:
4.2
作者:
[Cole ES, Drake C, DiDomenico E, Sharbaugh M, Kim JY, Nagy D, Cochran G, Gordon AJ, Gellad WF, Pringle J, Warwick J, Chang CH, Kmiec J, Kelley D, Donohue JM]
通讯作者:
Donohue JM
DOI:
10.1097/adm.0000000000000727
发表时间:
2020
期刊:
Journal of addiction medicine
影响因子:
5.5
作者:
[Drake C, Yu J, Lurie N, Kraemer K, Polsky D, Chaiyachati KH]
通讯作者:
Chaiyachati KH
共 8 条
Geographic Access to Medication Assisted Treatment for Medicaid Enrollees with Opioid Use Disorder
-
批准号:10037952
-
项目类别:
-
资助金额:$17.26万
-
财政年份:2020
-
负责人:Coleman Drake
-
依托单位:
Geographic Access to Medication Assisted Treatment for Medicaid Enrollees with Opioid Use Disorder
-
批准号:10200741
-
项目类别:
-
资助金额:$17.31万
-
财政年份:2020
-
负责人:Coleman Drake
-
依托单位:
海外基金